Liquidia Corp. (LQDA)
67.66
-2.28
(-3.26%)
USD |
NASDAQ |
Aug 28, 16:00
67.99
+0.33
(+0.49%)
After-Hours: 18:34
Liquidia Cash from Operations (Quarterly) : 80.24M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 80.24M |
| March 31, 2026 | 52.99M |
| December 31, 2025 | 44.24M |
| September 30, 2025 | -9.77M |
| June 30, 2025 | -39.48M |
| March 31, 2025 | -30.68M |
| December 31, 2024 | -20.81M |
| September 30, 2024 | -25.08M |
| June 30, 2024 | -22.66M |
| March 31, 2024 | -24.87M |
| December 31, 2023 | -15.98M |
| September 30, 2023 | -11.56M |
| June 30, 2023 | -5.564M |
| March 31, 2023 | -8.457M |
| December 31, 2022 | -4.603M |
| September 30, 2022 | -5.774M |
| June 30, 2022 | -8.429M |
| March 31, 2022 | -9.782M |
| December 31, 2021 | -7.559M |
| Date | Value |
|---|---|
| September 30, 2021 | -5.830M |
| June 30, 2021 | -8.260M |
| March 31, 2021 | -12.39M |
| December 31, 2020 | -14.09M |
| September 30, 2020 | -12.51M |
| June 30, 2020 | -13.11M |
| March 31, 2020 | -14.44M |
| December 31, 2019 | -14.06M |
| September 30, 2019 | -11.95M |
| June 30, 2019 | -12.16M |
| March 31, 2019 | -10.11M |
| December 31, 2018 | -8.329M |
| September 30, 2018 | -6.280M |
| June 30, 2018 | -7.222M |
| March 31, 2018 | -10.00M |
| December 31, 2017 | -4.662M |
| September 30, 2017 | -5.253M |
| June 30, 2017 | -5.333M |
| March 31, 2017 | -9.042M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 228.52M |
| Harmony Biosciences Holdings, Inc. | 92.43M |
| Johnson & Johnson | 8.616B |
| Amneal Pharmaceuticals, Inc. | -21.24M |
| Corcept Therapeutics, Inc. | 33.54M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -12.24M |
| Cash from Financing (Quarterly) | -6.614M |
| Free Cash Flow | 150.69M |
| Free Cash Flow Per Share (Quarterly) | 0.6806 |
| Free Cash Flow to Equity (Quarterly) | 70.94M |
| Free Cash Flow to Firm (Quarterly) | 74.77M |
| Free Cash Flow Yield | 2.29% |